Inventiva (IVA) Non-Current Debt (2018 - 2025)

Inventiva (IVA) recorded quarterly Non-Current Debt of $58.4 billion in Q2 2025, up 12.79% quarter-over-quarter from $51.8 billion in Q4 2024, and up 115678.89% on a YoY basis from N/an in Q2 2024.

Inventiva (IVA) Non-Current Debt (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Debt history runs 8 years deep, the most recent figure standing at $58.4 billion for Q2 2025.

  • In Q2 2025, Non-Current Debt rose 115678.89% year-over-year to $58.4 billion; the TTM figure through Jun 2025 stood at $58.4 billion (up 115678.89% YoY), while the FY2024 annual figure was $51.8 billion, changed N/A from the prior year.
  • Non-Current Debt was $58.4 billion for Q2 2025 at Inventiva, up from $51.8 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $58.4 billion in Q2 2025 to a low of $10.1 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $13.9 billion across 5 years, with a median of $33.8 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Debt jumped 118026.67% in 2022, then slumped 99.76% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $10.1 million in 2021, then soared by 189.27% to $29.2 million in 2022, then advanced by 15.49% to $33.8 million in 2023, then jumped by 153234.97% to $51.8 billion in 2024, then climbed by 12.79% to $58.4 billion in 2025.
  • The last three Non-Current Debt figures came in at $58.4 billion (Q2 2025), $51.8 billion (Q4 2024), and $50.4 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 Inventiva 8.93 Mn -259.80 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 58.41 Bn
Jun 30, 2025 58.41 Bn
Dec 31, 2024 51.78 Bn
Dec 31, 2024 51.78 Bn
Jun 30, 2024 50.45 Mn
Jun 30, 2024 50.45 Mn
Jun 30, 2023 33.77 Mn
Jun 30, 2023 33.77 Mn
Dec 31, 2022 29.24 Mn
Dec 31, 2022 29.24 Mn
Jun 30, 2022 14.34 Bn
Jun 30, 2022 14.34 Bn
Dec 31, 2021 10.11 Mn
Dec 31, 2021 10.11 Mn
Jun 30, 2021 12.14 Mn
Jun 30, 2021 12.14 Mn
Mar 31, 2021 12.15 Mn
Mar 31, 2021 12.15 Mn
Dec 31, 2020 11.97 Mn
Dec 31, 2020 11.97 Mn